These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34180463)

  • 21. SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms.
    Mosbech H; Canonica GW; Backer V; de Blay F; Klimek L; Broge L; Ljørring C
    Ann Allergy Asthma Immunol; 2015 Feb; 114(2):134-40. PubMed ID: 25624131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Intervention Improves Clinical Responses to House Dust Mite Immunotherapy in Allergic Rhinitis Patients.
    Qi S; Chen H; Huang N; Li W; Liu G; Wang Y; Hu L; Wang X; Zhang W; Zhu R
    Int Arch Allergy Immunol; 2016; 171(3-4):234-240. PubMed ID: 28049194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
    Richards JR; Stumpf JL
    Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma.
    Farraia M; Paciência I; Castro Mendes F; Cavaleiro Rufo J; H Shamji M; Agache I; Moreira A
    Allergy; 2022 Sep; 77(9):2688-2698. PubMed ID: 35451128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [DIFFERENCE BETWEEN STANDARDIZED MITE ANTIGEN AND HOUSE DUST EXTRACT IN RUSH SUBCUTANEOUS IMMUNOTHERAPY FOR CHILDREN].
    Tanaka Y; Okafuji I; Omae S; Mitobe Y; Doi K; Tsuruta S
    Arerugi; 2019; 68(6):681-690. PubMed ID: 31308334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term efficacy of standardised specific subcutaneous immunotherapy in children with persistent allergic rhinitis due to multiple allergens including house dust mites.
    Song Y; Long J; Wang T; Xie J; Wang M; Tan G
    J Laryngol Otol; 2018 Mar; 132(3):230-235. PubMed ID: 29374499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergen immunotherapy for allergic asthma: The future seems bright.
    Diamant Z; van Maaren M; Muraro A; Jesenak M; Striz I
    Respir Med; 2023; 210():107125. PubMed ID: 36702170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis.
    Demoly P; Okamoto Y; Yang WH; Devillier P; Bergmann KC
    Expert Rev Clin Immunol; 2016 Nov; 12(11):1141-1151. PubMed ID: 27632814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USA.
    Guan K; Liu B; Wang M; Li Z; Chang C; Cui L; Wang RQ; Wen LP; Leung PSC; Wei JF; Sun JL
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):128-143. PubMed ID: 31243705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-II genes are associated with outcomes of specific immunotherapy for allergic rhinitis.
    Zhao Y; Zhao Y; Zhang Y; Zhang L
    Int Forum Allergy Rhinol; 2019 Nov; 9(11):1311-1317. PubMed ID: 31299142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis.
    Bozek A; Kozłowska R; Misiołek M; Ścierski W; Gawlik R
    Hum Vaccin Immunother; 2022 Nov; 18(6):2097818. PubMed ID: 35816437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of house dust mite sublingual immunotherapy on the TSLP-OX40L signaling pathway in patients with allergic rhinitis.
    Meng Q; Liu X; Li P; He L; Xie J; Gao X; Wu X; Su F; Liang Y
    Int Forum Allergy Rhinol; 2016 Aug; 6(8):862-70. PubMed ID: 27012942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy.
    Bordas-Le Floch V; Berjont N; Batard T; Varese N; O'Hehir RE; Canonica WG; van Zelm MC; Mascarell L
    Allergy; 2022 Apr; 77(4):1263-1273. PubMed ID: 34551124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis.
    Demoly P; Kleine-Tebbe J; Rehm D
    Allergy; 2017 Oct; 72(10):1576-1578. PubMed ID: 28273339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark.
    Rønborg S; Johnsen CR; Theilgaard S; Winther A; Hahn-Pedersen J; Andreasen JN; Olsen J
    J Med Econ; 2016 Aug; 19(8):735-41. PubMed ID: 26909663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma.
    Agache I; Lau S; Akdis CA; Smolinska S; Bonini M; Cavkaytar O; Flood B; Gajdanowicz P; Izuhara K; Kalayci O; Mosges R; Palomares O; Papadopoulos NG; Sokolowska M; Angier E; Fernandez-Rivas M; Pajno G; Pfaar O; Roberts GC; Ryan D; Sturm GJ; van Ree R; Varga EM; van Wijk RG; Yepes-Nuñez JJ; Jutel M
    Allergy; 2019 May; 74(5):855-873. PubMed ID: 31095767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of intralymphatic allergen-specific immunotherapy on house dust mite in a murine model of allergic rhinitis.
    Jung JH; Kim KA; Choi YS; Kim ST
    Acta Otolaryngol; 2023 Oct; 143(10):867-875. PubMed ID: 38059621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.
    Wang ZX; Shi H
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):407-411. PubMed ID: 28585143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan.
    Ohashi-Doi K; Lund K; Mitobe Y; Okamiya K
    Biol Pharm Bull; 2020; 43(1):41-48. PubMed ID: 31902930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.